UK-based construction services provider Interserve Group has been chosen as a preferred bidder for a new £15m medicine production facility in Renfrewshire, Scotland.

Situated near Glasgow Airport, the new facility, known as Medicines Manufacturing Innovation Centre (MMIC), will be led CPI in collaboration with The University of Strathclyde, Scottish Enterprise, and AstraZeneca and GlaxoSmithKline.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The new facility, located in Inchinnan, will produce highly-efficient and effective technologies, strengthening the UK’s position in small molecule pharmaceutical and fine chemical manufacturing.

Interserve Construction regional director Cameron Stewart said: “The new centre at Inchinnan is a really exciting, innovative project where our strengths in the medical sector will hugely benefit the project.

“Interserve Constriction will bring our considerable experience and capabilities in delivering similar projects like the National Biologics Manufacturing Centre for CPI in Darlington, which is currently supporting efforts to manufacture and formulate vaccines for Covid-19, and the Jack Copeland Centre in Edinburgh for the Scottish National Blood Transfusion Service.”

See Also:

The production centre is financed by UK Research and Innovation through the UK Industrial Strategy Challenge Fund, Scottish Enterprise and founding industry partners GlaxoSmithKline and AstraZeneca.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Interserve said that the flexible and adaptable building will allow healthcare providers, industry, academia and regulators to work closely to ensure hassle-free operations in the medicines supply chain. 

CPI CEO Nigel Perry said: “The Medicines Manufacturing Innovation Centre will enhance the UK’s existing competitive advantage by deepening the skills base and strengthening the rationale for companies to invest in new, highly productive medicines manufacturing.

“CPI is delighted to be working alongside the University of Strathclyde, Innovate UK, Scottish Government and our industry partners to deliver this globally unique centre that will prepare the pharmaceutical supply chain for vital, next-generation medicines and further extend CPI’s healthcare capabilities.”

————————————————————————————————————————————–

The new production centre will develop highly efficient and effective technologies. (Credit: Interserve)